
zzso a zzso zzso zzso is being developed for prevention and treatment of osteoporosis and for risk reduction of invasive breast cancer in zzso zzso 

The effects of zzso 20 zzso on bone mineral density zzso zzso safety, and overall safety were studied in the zzso study, a zzso randomized, zzso trial including 331 zzso women with normal to low bone zzso 

Compared to zzso zzso significantly increased zzso spine zzso and total hip zzso zzso zzso decreased zzso markers of bone metabolism compared to zzso Changes in breast density were neutral or slightly decreased in the zzso zzso zzso zzso There was no evidence of zzso zzso or zzso in the zzso group as assessed by central review of baseline and follow-up zzso zzso There was no significant change between the groups in zzso thickness assessed by zzso zzso The zzso of zzso zzso and zzso bleeding was not significantly different between the zzso zzso zzso infection was the only adverse event significantly increased in the zzso zzso zzso zzso Hot zzso were not significantly different between the zzso 

In zzso women with normal to low bone mass, zzso 20 zzso increased zzso at the spine and hip and had a neutral effect on the zzso and zzso 

